AR055590A1 - Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos - Google Patents

Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos

Info

Publication number
AR055590A1
AR055590A1 ARP060103258A ARP060103258A AR055590A1 AR 055590 A1 AR055590 A1 AR 055590A1 AR P060103258 A ARP060103258 A AR P060103258A AR P060103258 A ARP060103258 A AR P060103258A AR 055590 A1 AR055590 A1 AR 055590A1
Authority
AR
Argentina
Prior art keywords
substituted
alkyl
aryl
cycloalkyl
group
Prior art date
Application number
ARP060103258A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR055590A1 publication Critical patent/AR055590A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Estos compuesto son utiles para la contracepcion y terapia de reemplazo hormonal. Composicion farmacéutica. Reivindicacion 1: Un compuesto que tiene la estructura de la formula (1) o su sal aceptable para uso farmacéutico donde: R1 se selecciona del grupo que consiste en: H, CN, C(O)-alquilo C1-6, C(O)-cicloalquilo C3-8, C(O)-alquilo C1-6 sustituido, C(O)-arilo, C(O)-arilo sustituido, C(O)-heteroarilo, C(O)-heterociclo, C(O)-alquenilo C3-6, C(O)-alquinilo C3-6, C(O)-alquenilo C3-6 sustituido, C(O)-alquinilo C3-6 sustituido, C(O)O-alquilo C1-6, C(O)O-cicloalquilo C3-8, C(O)O-alquilo C1-6 sustituido, C(O)O-arilo, C(O)O-arilo sustituido, C(O)O-heteroarilo, C(O)O-heterociclo, C(O)O-alquenilo C3-6, C(O)O-alquinilo C3-6, C(O)O- alquenilo C3-6 sustituido, C(O)O-alquinilo C3-6 sustituido, C(O)NH-alquilo C1-6, C(O)NH-cicloalquilo C3-8, C(O)N-di-cicloalquilo C3-8, C(O)N-dialquilo C1-6, C(O)N-di-alquilo C1-6 sustituido, C(O)NH-alquilo C1-6 sustituido, C(O)NH-arilo, C(O)N-di- arilo, C(O)NH-arilo sustituido, C(O)N-di-arilo sustituido, C(O)NH-heteroarilo, C(O)N-di-heteroarilo, C(O)NH-heterociclo, C(O)N-di-heterociclo, C(O)NH-alquenilo C3-6, C(O)NH-alquinilo C3-6, C(O)NH-alquenilo C3-6 sustituido, y C(O)NH-alquinilo C3-6 sustituido; o R1 es un grupo de union a una segunda estructura de formula (1) para formar un dímero de formula (1), dicho grupo de union es un grupo C(O); R2 se selecciona del grupo que consiste en H, alquilo C1-6, alquilo C1-6 sustituido y cicloalquilo C3-6; con la condicion de que R1 y R2 no son H; con la condicion de que donde R1 es C(O)arilo sustituido, R2 no es H; con la condicion de que cuando R1 es H y R7 es H, R2 no es alquilo C1-6; R3, R4, R5 y R6 se seleccionan independientemente del grupo que consiste en H, halogeno, alquilo C1-6, alquilo C1-6 sustituido, cicloalquilo C3-6, O-alquilo C1-6, O-alquilo C1-6 sustituido, arilo, heteroarilo, heterociclo, arilo sustituido, heteroarilo sustituido y heterociclo sustituido; y R7 se selecciona del grupo que consiste en H, alquilo C1-6, alquilo C1-6 sustituido, cicloalquilo C3-6 y cicloalquilo C3-6 sustituido.
ARP060103258A 2005-07-29 2006-07-27 Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos AR055590A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70400805P 2005-07-29 2005-07-29

Publications (1)

Publication Number Publication Date
AR055590A1 true AR055590A1 (es) 2007-08-29

Family

ID=37309008

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103258A AR055590A1 (es) 2005-07-29 2006-07-27 Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos

Country Status (13)

Country Link
US (2) US7297713B2 (es)
EP (1) EP1910284A1 (es)
JP (1) JP2009502946A (es)
CN (1) CN101233103A (es)
AR (1) AR055590A1 (es)
AU (1) AU2006275832A1 (es)
BR (1) BRPI0614413A2 (es)
CA (1) CA2613484A1 (es)
GT (1) GT200600335A (es)
MX (1) MX2008001337A (es)
PE (1) PE20070182A1 (es)
TW (1) TW200728274A (es)
WO (1) WO2007016211A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
TW200848019A (en) * 2007-03-06 2008-12-16 Wyeth Corp Aryl sulfonamides useful for modulation of the progesterone receptor
TW200848021A (en) * 2007-03-06 2008-12-16 Wyeth Corp Sulfonylated heterocycles useful for modulation of the progesterone receptor
CA2710293A1 (en) * 2007-12-20 2009-07-02 Teva Women's Health, Inc. Dosage regimens and pharmaceutical compositions and packages for emergency contraception
BRPI1003661A2 (pt) * 2010-09-15 2013-01-08 Libbs Farmaceutica Ltda associaÇço farmacÊutica para tratar e/ou prevenir mioma e/ou endometriose, uso de resveratrol e progestogenio, composiÇço farmacÊutica para tratamento e/ou prevenÇço de mioma e/ou endometriose medicamento para tratamento e/ou prevenÇço de mioma e/ou endometrios, kit e mÉtodo para tratamento e/ou prevenÇço de mioma e/ou endometriose
WO2014202505A1 (de) 2013-06-20 2014-12-24 Bayer Cropscience Ag Arylsulfid- und arylsulfoxid-derivate als akarizide und insektizide

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051322A (es) 1967-08-09
GB1215858A (en) 1968-05-03 1970-12-16 Merck & Co Inc Nitroimidazole derivatives
US4315009A (en) 1978-01-18 1982-02-09 Imperial Chemical Industries Limited Antisecretory guanidine derivatives and pharmaceutical compositions containing them
DE3168754D1 (en) 1980-07-09 1985-03-21 Beecham Group Plc Clonidine derivatives useful in the treatment of diarrhoea
US4680413A (en) 1986-01-17 1987-07-14 Nippon Soda Co., Ltd. Process for the production of 3-phenyl-4-cyanopyrroles
US5310938A (en) 1987-07-29 1994-05-10 American Cyanamid Company Substituted arylpyrrole compounds
US4857651A (en) 1987-07-29 1989-08-15 American Cyanamid Company α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof
US4929634A (en) 1987-10-23 1990-05-29 American Cyanamid Company Method of and bait compositions for controlling mollusks
DE3814057A1 (de) 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0358047A3 (en) 1988-09-08 1991-05-29 American Cyanamid Company Method of controlling phytopathogenic fungi
GB8903592D0 (en) 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
DE69026906T2 (de) 1989-08-11 1996-11-28 American Cyanamid Co., Wayne, N.J. Arylpyrrol enthaltende insekticidale, acaricidale und nematicidale Mittel sowie Verfahren zu ihrer Herstellung
US5328928A (en) 1990-05-11 1994-07-12 American Cyanamid Company N-acylated arylpyrroles useful as insecticidal, agents
EP0484614B1 (en) 1990-05-11 1995-05-24 American Cyanamid Company N-acylated arylpyrroles useful as insecticidal, acaricidal, nematicidal and molluscicidal agents
IN172842B (es) 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
US5215994A (en) 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
US5210092A (en) 1990-09-25 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Angiotensin ii antagonizing heterocyclic derivatives
DE4036645A1 (de) 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
US5151536A (en) 1990-12-17 1992-09-29 American Cyanamid Company Process for the manufacture of pesticidal 1-(alkoxymethyl) pyrrole compounds
DE4102024A1 (de) 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5847006A (en) 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5354759A (en) 1991-09-12 1994-10-11 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic compounds
GB9201789D0 (en) 1992-01-28 1992-03-11 Fujisawa Pharmaceutical Co Heterocyclic derivatives
WO1993019067A1 (en) 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
US5306827A (en) 1991-12-04 1994-04-26 American Cyanamid Company Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole insecticidal and acaricidal agents
US5284863A (en) 1991-12-04 1994-02-08 American Cyanamid Company Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole fungicidal agents
GB9202633D0 (en) 1992-02-07 1992-03-25 Fujisawa Pharmaceutical Co Heterocyclic derivatives
GB9217820D0 (en) 1992-08-21 1992-10-07 Fujisawa Pharmaceutical Co New use
US5449789A (en) 1992-11-30 1995-09-12 American Cyanamid Company Debrominative chlorination of pyrroles
US5518891A (en) 1993-03-25 1996-05-21 Actimed Laboratories, Inc. Dye forming composition and detection of hydrogen peroxide therewith
TW283246B (es) * 1994-02-17 1996-08-11 Mitsubishi Electric Machine
WO1995022520A1 (en) 1994-02-17 1995-08-24 American Home Products Corporation Substituted biphenyl derivatives as phosphodiesterase inhibitors
US20010020100A1 (en) 1994-06-14 2001-09-06 G.D. Searle & Co. N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders
DE19515177A1 (de) 1995-04-28 1996-10-31 Cassella Ag Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe
ATE231501T1 (de) 1995-05-18 2003-02-15 Altana Pharma Ag Phenyldihydrobenzofurane
US5932520A (en) 1995-05-23 1999-08-03 American Cyanamid Company Use of pyrrole compounds as antifouling agents
US6242613B1 (en) 1996-08-02 2001-06-05 American Cyanamid Co. Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them
IL121430A (en) 1996-08-02 2002-03-10 American Cyanamid Co Process for the preparation of arylpyrrole particles in the form of stable crystals and concentrated suspending preparations containing stable arylpyrrole particles, which are a product of the process
US6541499B1 (en) 1997-05-01 2003-04-01 Eli Lilly And Company Antithrombotic agents
SG72827A1 (en) 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
TW460460B (en) 1997-11-04 2001-10-21 Chugai Pharmaceutical Co Ltd Heterocyclic compounds having NOS inhibitory activities
AUPP873799A0 (en) 1999-02-17 1999-03-11 Fujisawa Pharmaceutical Co., Ltd. Pyridine compounds
HUP0201314A3 (en) 1999-03-26 2003-02-28 Euro Celtique Sa Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof and pharmaceutical compositions containing them
DE19918725A1 (de) 1999-04-24 2000-10-26 Bayer Ag Substituierte N-Cyano-sulfonsäureanilide
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6403629B2 (en) 2000-05-02 2002-06-11 J.B. Chemical And Pharmaceuticals Limited Heterocyclic compounds for therapeutic use
BR0207957A (pt) 2001-03-09 2004-02-25 Pfizer Prod Inc Compostos antiinflamatórios de benzimidazol
JP4130774B2 (ja) 2001-03-09 2008-08-06 ファイザー・プロダクツ・インク 抗炎症薬としてのトリアゾロピリジン類
ES2247271T3 (es) 2001-04-04 2006-03-01 Pfizer Products Inc. Nuevos benzotriazoles como compuestos antiinflamatorios.
ITBO20010271A1 (it) 2001-05-08 2002-11-08 Giuseppe Cannazza Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl
FR2824827B1 (fr) 2001-05-17 2004-02-13 Fournier Lab Sa Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
US6855269B2 (en) 2001-11-09 2005-02-15 Cytec Technology Corp. Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers
JP2005537228A (ja) 2002-04-25 2005-12-08 ファルマシア・コーポレーション ピペリジニル−及びピペラジニル−スルホニルメチルヒドロキサム酸並びにプロテアーゼ阻害剤としてのその使用
EP1549635A1 (en) 2002-09-27 2005-07-06 Janssen Pharmaceutica N.V. 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
WO2004039795A2 (en) 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
US20060089371A1 (en) 2002-11-11 2006-04-27 Bayer Healthcare Ag Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
GB0230088D0 (en) 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302671D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
CA2515440A1 (fr) 2003-02-12 2004-09-02 L'oreal Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
CN1946716B (zh) * 2004-04-27 2011-12-21 惠氏公司 含有氰基吡咯的环状氨基甲酸酯和硫代氨基甲酸酯联芳基以及其制备方法
GT200500183A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
PE20070404A1 (es) * 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona

Also Published As

Publication number Publication date
CN101233103A (zh) 2008-07-30
US20070027125A1 (en) 2007-02-01
AU2006275832A1 (en) 2007-02-08
GT200600335A (es) 2007-05-28
WO2007016211A1 (en) 2007-02-08
BRPI0614413A2 (pt) 2016-11-22
US7297713B2 (en) 2007-11-20
US20080064673A1 (en) 2008-03-13
US7652062B2 (en) 2010-01-26
CA2613484A1 (en) 2007-02-08
JP2009502946A (ja) 2009-01-29
EP1910284A1 (en) 2008-04-16
PE20070182A1 (es) 2007-03-06
TW200728274A (en) 2007-08-01
MX2008001337A (es) 2008-03-25

Similar Documents

Publication Publication Date Title
AR055590A1 (es) Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
PE20220592A1 (es) Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos
PE20221910A1 (es) Derivados de pirazolilo utiles como agentes anticancerigenos
AR120682A1 (es) Compuestos de benzotiadiazepina y su uso como moduladores del ácido biliar
AR120679A1 (es) Compuestos de benzoti(di)azepina y su uso como moduladores ácido biliar
UY29316A1 (es) Miméticos de glucocorticoides, métodos para prepararlos, composiciones farmacéuticas, y usos de los mismos.
PE20090151A1 (es) Derivados de pirimidinona y metodos para su uso
ECSP066459A (es) Miméticos de glucocorticoides, métodos de preparación, composiciones farmacéuticas y usos de los mismos
AR120674A1 (es) Compuestos de benzotiazepina y su uso como ácido biliar
UY28157A1 (es) Miméticos de glucocorticoides métodos para su elaboración composiciones farmacéuticas y sus usos
AR120683A1 (es) Compuestos de benzoti(di)azepina y su uso como ácido biliar
AR126076A1 (es) Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
BR112022010383A2 (pt) Compostos tricíclicos substituídos
AR043508A1 (es) 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores
PE20060555A1 (es) Derivados de pirrol-oxindol como moduladores del receptor de progesterona
AR057380A1 (es) Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR049706A1 (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
AR047744A1 (es) Compuestos de triazol y su uso como antagonistas del receptor de glutamato metabotropico
AR026122A1 (es) Derivados de 3(5)-amino-pirazol, procedimiento para su preparacion y su uso como agente antitumorales
PE20060691A1 (es) Serinamidas sustituidas por benzoilo
AR033344A1 (es) Compuestos derivados de benzofenonas como inhibidores de la transcriptasa inversa, su uso en la fabricacion de medicamentos, intermediarios y composiciones farmaceuticas
AR060623A1 (es) Compuestos derivados de 2-azetidinona y un metodo de preparacion
AR059176A1 (es) Compuesto de indol, composicion farmaceutica que lo comprende, metodo para prepararlo y su uso para preparar dicha composicion y para la manufactura de un medicamento para el tratamiento o prevencion de leiomiomas y endometriosis.
RU2008123388A (ru) Соединения и композиции в качестве модуляторов lxr

Legal Events

Date Code Title Description
FA Abandonment or withdrawal